Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
3,074.70
2,892.70
2,951.10
2,885.50
2,830.70
2,146.70
1,843.60
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
3,074.70
2,892.70
2,951.10
2,885.50
2,830.70
2,146.70
1,843.60
Raw Material Cost
1,970.20
1,890.50
1,818.40
1,746.60
1,657.30
1,378.80
1,234.80
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.40
2.90
8.80
7.60
8.50
8.50
8.00
Selling and Distribution Expenses
393.60
338.50
353.40
316.90
361.90
302.00
272.70
Other Expenses
7.39
6.62
5.96
5.09
4.43
3.84
3.09
Total Expenditure (Excl Depreciation)
2,438.10
2,298.10
2,240.20
2,122.00
2,072.00
1,727.70
1,546.40
Operating Profit (PBDIT) excl Other Income
636.5999999999999
594.6
710.9000000000001
763.5
758.7
419
297.2
Other Income
7.40
12.80
9.70
-39.80
2.60
-5.60
10.00
Operating Profit (PBDIT)
815.40
762.80
857.90
844.30
883.60
522.50
410.60
Interest
0.40
2.90
8.80
7.60
8.50
8.50
8.00
Exceptional Items
-42.70
-19.00
-13.80
-36.20
-3.90
-3.60
-7.40
Gross Profit (PBDT)
1,104.50
1,002.20
1,132.70
1,138.90
1,173.40
767.90
608.80
Depreciation
171.40
155.40
137.30
120.60
122.30
109.10
103.40
Profit Before Tax
600.90
585.50
698.00
679.90
748.90
401.30
291.80
Tax
121.60
107.50
122.30
114.70
107.20
72.50
59.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
493.70
492.70
593.40
585.90
661.80
346.20
241.70
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
493.70
492.70
593.40
585.90
661.80
346.20
241.70
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
493.70
492.70
593.40
585.90
661.80
346.20
241.70
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.25
0.25
0.25
0.25
0.25
0.25
0.25
Reserves
3,176.00
2,682.30
2,881.00
2,684.90
2,335.40
1,854.50
1,573.20
Earnings per share (EPS)
6.79
6.69
7.88
7.73
8.67
4.57
3.21
Diluted Earnings per share
6.79
6.69
7.88
7.73
8.67
4.57
3.21
Operating Profit Margin (Excl OI)
20.7%
20.56%
24.09%
26.46%
26.8%
19.52%
16.12%
Gross Profit Margin
25.12%
25.61%
28.3%
27.74%
30.78%
23.78%
21.44%
PAT Margin
16.06%
17.03%
20.11%
20.3%
23.38%
16.13%
13.11%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 6.29% vs -1.98% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 0.20% vs -16.97% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 7.73% vs -11.58% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is -86.21% vs -67.05% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of West Pharmaceutical Services, Inc. With
Figures in Million
Consolidate Annual Results
Change(USD)
Change(%)
Net Sales
3,074.70
20,625.00
-17,550.30
-85.09%
Other Operating Income
0.00
0.00
0.00
Total Operating income
3,074.70
20,625.00
-17,550.30
-85.09%
Raw Material Cost
1,970.20
12,436.00
-10,465.80
-84.16%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.40
484.00
-483.60
-99.92%
Selling and Distribution Expenses
393.60
4,033.00
-3,639.40
-90.24%
Other Expenses
7.39
77.60
-70.21
-90.48%
Total Expenditure (Excl Depreciation)
2,438.10
17,729.00
-15,290.90
-86.25%
Operating Profit (PBDIT) excl Other Income
636.60
2,896.00
-2,259.40
-78.02%
Other Income
7.40
372.00
-364.60
-98.01%
Operating Profit (PBDIT)
815.40
3,846.00
-3,030.60
-78.80%
Interest
0.40
484.00
-483.60
-99.92%
Exceptional Items
-42.70
-16.00
-26.70
-166.88%
Gross Profit (PBDT)
1,104.50
8,189.00
-7,084.50
-86.51%
Depreciation
171.40
578.00
-406.60
-70.35%
Profit Before Tax
600.90
2,768.00
-2,167.10
-78.29%
Tax
121.60
614.00
-492.40
-80.20%
Provisions and contingencies
0
0
0.00
Profit After Tax
493.70
2,084.00
-1,590.30
-76.31%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
493.70
2,084.00
-1,590.30
-76.31%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
70.00
-70.00
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
493.70
2,154.00
-1,660.30
-77.08%
Equity Capital
0
0
0.00
Face Value
0.25
0.01
0.00
Reserves
3,176.00
10,379.00
-7,203.00
-69.40%
Earnings per share (EPS)
6.79
4.55
2.24
49.23%
Diluted Earnings per share
6.79
4.55
2.24
49.23%
Operating Profit Margin (Excl OI)
20.70%
14.04%
0.00
6.66%
Gross Profit Margin
25.12%
16.22%
0.00
8.90%
PAT Margin
16.06%
10.10%
0.00
5.96%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 307.47 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 6.29% vs -1.98% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 49.37 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 0.20% vs -16.97% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 80.80 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 7.73% vs -11.58% in Dec 2024
Annual - Interest
Interest 0.04 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -86.21% vs -67.05% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 20.70%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
